New product vs established brand investment?
A trade-off you no longer have to make in this changing world
2nd November 2020
Thought Leadership
Changing gear – how to take patient-centricity to the next level
Truly achieving a patient-focused cultural shift means pharma leaders must build momentum behind the necessity of partnering with patients to capture and incorporate their valuable insights, say Dawn Lobban and Peter Impey
3rd September 2020
Partnering with patients for the long haul
O4 Research's Moneeb Saddiq and Andrea Parke consider whether the patient-centricity story is complete or still evolving
3rd September 2020
Pharma and the modern patient: creating a real connection
Eliran Malki, co-founder and CEO of Belong.Life, explores what pharma can do to engage the modern patient
3rd September 2020
Decentralised and hybrid trials – the patient’s voice
ICON's Gretchen Goller on getting the patient perspective on clinical trial participation
3rd September 2020
Patient-centricity in rare diseases
Keeping the needs of patients as a guiding principle has been key to Kyowa Kirin's recent success, says Richard Johnson
3rd September 2020
Changing Landscape of Clinical Trials Data Capture and Reporting during Covid 19 Pandemic
On January 30, 2020, the WHO declared the novel acute respiratory infection caused by the “SARS-CoV-2” virus, termed “Coronavirus Disease-2019 (COVID-19)” as a Public Health Emergency of International Concern.{9} As of July 20, 2020, over 14 million people worldwide are confirmed to be infected, leading to increasing fatality rates.{10}
12th August 2020
The concordance conundrum: creating space for open dialogue between patients and HCPs
Creating space for open dialogue between patients and healthcare professionals
20th July 2020
